Brought to you by:
MVSS 2022: Study finds no link between frailty score and surgical site infection
A vascular surgery-specific composite frailty score was not associated with with risk of surgical site infection in patients undergoing lower-extremity revascularization in a review carried out by Andrew Edsall, MD, a general surgery resident in the Gundersen Health System in…
BEST-CLI: Optimal medical therapy adherence ‘well below’ recommended level at baseline
A significant proportion of patients enrolled in the BEST-CLI trial did not meet optimal medical therapy (OMT) guideline-based recommendations at the time of their entry into the study, co-principal investigator Matthew Menard, MD, told the 2022 New England Society for…
Miss the SVS webinars? Take advantage of the recordings
The Society for Vascular Surgery (SVS) hosts a number of Town Halls, roundtables and webinars for the benefit of its members. In the past few months, members were able to participate in a webinar on how best to use electronic…
Cyclical topical wound oxygen therapy: A new generation of wound healing device showing sustained results
This advertorial is sponsored by AOTI. In the beginning, it took a little convincing for Anil Hingorani, MD, to come around to the idea that cyclical Topical Wound Oxygen Therapy (TWO2) could be the sort of device he would add…
Chocolate Touch DCB for treatment of peripheral arterial disease receives FDA approval
Genesis MedTech Group announced that the Food and Drug Administration (FDA) has approved the Chocolate Touch drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter developed by TriReme Medical for the treatment of patients with peripheral arterial disease (PAD) in the…
‘Significant’ increase in atherectomy use in US largely driven by office-based procedures, VQI data show
In the United States, atherectomy use in peripheral vascular interventions (PVIs) “more than doubled” from 2010 to 2019, with office-based procedures a “major driver” of this increase. This is according to published U.S. data from the Vascular Quality Initiative (VQI),…
End-stage CLTI: Deep-vein arterialization procedure demonstrates amputation-free survival rate of 66% at six months
Six-month results from the PROMISE II trial of the LimFlow deep-vein arterialization system showed an overall amputation-free survival of 66%—“well above” the primary endpoint target of 54%, chief investigator Daniel Clair, MD, told the 2022 Vascular Interventional Advances (VIVA) meeting…
Study: Combined antiplatelet, NOAC use linked to worse limb outcomes after suprainguinal bypass
A new analysis that found combined antiplatelet and novel oral anticoagulant (NOAC) therapy after suprainguinal bypass was associated with worse limb outcomes and equivalent survival compared to antiplatelet use alone has “weaknesses” but is “hypothesis-generating,” the senior author insisted during…
The top 10 most popular Vascular Specialist stories of September 2022
September’s top stories featured news of a trial to evaluate women’s experience of early endovascular aneurysm repair, and of a special women-focused edition of the Annals of Vascular Surgery. A guest commentary on the importance of advocacy in vascular surgery…
Only a few seats remain for CPVI hands-on skills course
Only a few spots remain available for the Society for Vascular Surgery’s new Complex Peripheral Vascular Intervention (CPVI) Skills Course. Today—Thursday, Oct. 20—is the final day to register. The interactive course will be held Oct. 23 and 24 at the…